RANKL-dependent osteoclastogenesis signaling pathways are the main regulatory pathways related to overactivation of osteoclasts in bone disorders.37 Numerous miRNAs have been shown to be differentially expressed during osteoclast differentiation and exert crucial roles in RANKL-dependent osteoclast activation in RA. This evidence concerns the gene TNFSF11 and bone disorder.